Johnna Byrd began taking Zepbound to help her finish the weight loss journey she started. She never imagined it would help ...

GoodRx reports GLP-1 weight-loss pills are emerging, with candidates like orforglipron and oral semaglutide likely to gain ...

Compounded weight loss drugs have been mostly off the market for about a month, but the weight loss drug industry remains as ...

For reference, Novo Nordisk also offers a highly successful weight loss drug, Wegovy, a GLP-1 receptor agonist.

A monthly weight loss drug from Amgen helped people lose about 20% of their body weight, according to the results of a phase ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...

The World Health Organization continues its investigation into the origins of COVID-19, with significant information still ...

In what she calls the "wild west" of obesity medicines, Missouri-based Amy Spencer is a pioneer.

At the diabetes conference, Eli Lilly presented results of a phase 1 trial of its experimental drug, eloralintide. Unlike GLP ...

If the drug is more broadly used in people with obesity and not just diabetes, those with higher body weights may see even ...

Novo Nordisk has launched its weight-loss drug Wegovy in India, while Eli Lilly's Mounjaro has received regulatory approval, ...